Medicaid program gets boost from pharmaceutical settlement

Settlement gives Medicaid a cash injection.
Settlement gives Medicaid a cash injection.

HARTFORD, Conn. – Connecticut’s Medicaid program received $388,145 this month as part of a broader $56.5 million settlement that states and the federal government reached with Shire Pharmaceuticals.

The settlement resolves allegations that Philadelphia-based Shire “inappropriately” marketed several drugs for uses that have not been approved by the U.S. Food and Drug Administration. Terms of the agreement recently were announced by state Attorney General George Jepsen, Chief State’s Attorney Kevin Kane and state Department of Social Services Commissioner Roderick Bremby.

Connecticut and other states allege that Shire made claims about the drugs without sufficient clinical data to support them and without the backing of the FDA, according to state officials. The drugs involved are Adderall XR, Vyvanse, Daytrona, Lialda and Pentasa, and the misleading marketing took place between February 2007 and September 2010.

See the complete story at CT News Junkie.


Leave a Reply

Recent Comments